This month’s healthcare and pharmaceutical coverage highlights how political pressure, regulatory changes, and new technologies are reshaping access to care and influencing public trust. From government action on drug pricing and funding cuts to HIV programs to debates over AI-driven health advice, the industry faces complex challenges at the intersection of innovation, affordability, and safety. […]
This month’s healthcare and pharmaceutical headlines reflect the growing influence of politics, corporate strategy, and innovation on public health. Limited FDA approval of some COVID vaccines, major acquisitions to expand treatment portfolios, and advances in AI-assisted fertility care show how decisions around access, investment, and technology are shaping the industry. These developments signal a shift […]
This month’s healthcare and pharmaceutical headlines reflect increased scrutiny of public health decisions, regulatory actions, and funding priorities. Changes in advisory panels, shifts in government spending, and the adoption of new technologies influence how treatments are approved, funded, and perceived. These developments underscore the growing intersection of science, politics, and public opinion. As healthcare policy […]
The Evolving Healthcare Media Landscape What’s the best way to get a busy healthcare reporter’s attention in 2025? What topics interest biopharma journalists most this year? How can you ensure your healthcare pitch stands out in an increasingly competitive digital environment? As the healthcare industry continues to evolve rapidly, so do the strategies for effectively […]
May’s top healthcare stories highlight major shifts in drug pricing policies, data-driven health initiatives, and advances in genetic medicine. Public and media attention is focused on government-led cost reforms and growing concerns over transparency and ethics in healthcare research. At the same time, new developments in personalized medicine offer cautious optimism for rare disease treatment. […]
This month’s healthcare and pharmaceutical news highlights several key stories that are drawing widespread media traction and public interest. From lawsuits and controversial health claims to drug pricing reforms, these developments have significant implications for both national and global health policy. Each story underscores the complex relationship between politics, public opinion, and healthcare. In this […]
This month’s healthcare news highlights public health governance updates involving the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), as well as trade restrictions affecting medical technology advancements. These events carry notable implications for the health and pharmaceutical sectors. To support informed decision-making, Fullintel Hub provides expert insights, in-depth […]
The International Public Relations Research Conference (IPRRC 2025) has once again proven why it remains the preeminent gathering for communications measurement innovation. This year’s event showcased groundbreaking research, new methodological approaches, and strategic frameworks that are reshaping how senior communications leaders demonstrate value to their organizations. As longstanding supporters and active participants in IPRRC, Fullintel […]
This month’s healthcare news highlights significant developments that have captivated global audiences and sparked ongoing conversations about leadership transitions, governmental efficiency, and the future of public health, both domestically and internationally. From high-profile nominations to comprehensive reforms in government agencies, the impact of these changes is poised to have a lasting influence on both national […]
Trust in pharmaceutical companies has increased since the pandemic, but as the least trusted subsector of healthcare, the industry still has a steep road to climb. However, by integrating messaging and content reaffirming key attributes of trustworthiness – including ability, benevolence, and integrity – pharmaceutical brands can continue building positive trust as the pandemic’s darkest […]
